18889881171
Kalkine 0
countryflagUS

BioLargo Inc

Basic Materials US BLGO

0.2125USD
0.0025(1.19%)

Last update at 2025-05-19T18:42:00Z

Day Range

0.200.21
LowHigh

52 Week Range

0.160.45
LowHigh

Fundamentals

  • Previous Close 0.21
  • Market Cap59.30M
  • Volume123396
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-3.63300M
  • Revenue TTM16.82M
  • Revenue Per Share TTM0.04
  • Gross Profit TTM 1.10M
  • Diluted EPS TTM-0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -5.13200M -6.89400M -9.70000M -11.44000M -10.69600M
Minority interest 0.66M -0.18600M -4.09300M -0.02700M 0.37M
Net income -4.47300M -7.08000M -8.43200M -10.69000M -10.22100M
Selling general administrative 6.73M 6.17M 7.47M 6.14M 5.26M
Selling and marketing expenses - - - - -
Gross profit 2.86M 1.10M 1.23M 0.92M 0.62M
Reconciled depreciation 0.04M 0.02M 0.06M 0.07M 0.05M
Ebit -5.13000M -6.37300M -7.47200M -6.63300M -6.33900M
Ebitda -5.03400M -6.64000M -7.71900M -7.37900M -7.15200M
Depreciation and amortization - - - - -
Non operating income net other - - - - 0.00000M
Operating income -5.11900M -6.31800M -7.33500M -6.41500M -6.18100M
Other operating expenses - -0.06300M -0.11100M -0.06300M 0.07M
Interest expense 0.05M 0.23M 1.92M 4.00M 3.49M
Tax provision - - - - -
Interest income - - - - -
Net interest income -0.05300M -0.23400M -1.92300M -3.99600M -3.49400M
Extraordinary items - - - - 0.00000M
Non recurring - - - - 0.00000M
Other items - - - - 0.00000M
Income tax expense - - - - 0.00000M
Total revenue 5.88M 2.53M 2.43M 1.86M 1.36M
Total operating expenses 11.00M 8.85M 9.77M 8.28M 7.54M
Cost of revenue 3.03M 1.43M 1.20M 0.94M 0.74M
Total other income expense net 0.04M -0.34200M -0.44200M -1.02900M -1.02100M
Discontinued operations - - - - 0.00000M
Net income from continuing ops -5.13200M -6.89400M -9.70000M -11.44000M -10.69600M
Net income applicable to common shares - -7.08000M -8.43200M -10.69000M -10.22100M
Preferred stock and other adjustments - - - - 0.00000M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 4.86M 3.02M 4.94M 3.62M 3.19M
Intangible assets 0.03M - 2.15M 1.89M 1.89M
Earning assets - - - - -
Other current assets 0.12M 0.09M 0.03M 0.04M 0.00000M
Total liab 2.85M 2.09M 5.18M 5.80M 4.31M
Total stockholder equity 4.88M 4.65M 3.86M -2.15300M -1.49600M
Deferred long term liab - - 2.15M 2.02M 2.07M
Other current liab 0.18M 0.17M 0.05M 0.04M 0.00000M
Common stock - 0.17M 0.15M 0.11M 0.10M
Capital stock 0.19M 0.17M 0.15M 0.11M 0.10M
Retained earnings -143.59400M -139.12100M -132.04100M -123.49200M -111.72300M
Other liab - - 0.90M 0.64M 0.64M
Good will - - - - 0.00000M
Other assets - 0.66M 2.97M 2.05M 2.10M
Cash 1.85M 0.96M 0.72M 0.66M 0.66M
Cash and equivalents - - - - -
Total current liabilities 1.58M 1.37M 3.54M 4.35M 2.49M
Current deferred revenue - - - - -
Net debt - - 1.62M 3.46M 2.51M
Short term debt - - - 3.59M 0.00000M
Short long term debt 0.10M 0.31M 2.33M 3.59M 1.99M
Short long term debt total - - - - -
Other stockholder equity - -0.11500M -0.10100M -0.09900M -0.09000M
Property plant equipment 1.15M 0.51M 0.40M 0.51M 0.13M
Total current assets 3.15M 1.80M 1.50M 1.06M 0.95M
Long term investments 0.03M 0.05M 0.06M - 0.00000M
Net tangible assets 4.88M 4.65M 3.86M -2.15300M -1.49600M
Short term investments - - - - 0.00000M
Net receivables 1.06M 0.51M 0.48M 0.35M 0.26M
Long term debt 0.50M 0.37M 0.51M 0.52M 1.17M
Inventory 0.12M 0.24M 0.28M 0.02M 0.03M
Accounts payable 0.90M 0.50M 0.72M 0.40M 0.30M
Total permanent equity - - - - 0.00000M
Noncontrolling interest in consolidated entity - - - - 0.00000M
Temporary equity redeemable noncontrolling interests - - - - 0.00000M
Accumulated other comprehensive income - - - - 0.00000M
Additional paid in capital - - - - 0.00000M
Common stock total equity - - - - 0.00000M
Preferred stock total equity - - - - 0.00000M
Retained earnings total equity - - - - 0.00000M
Treasury stock - - - - 0.00000M
Accumulated amortization - - - - 0.00000M
Non currrent assets other - 0.07M 0.04M 0.04M 0.04M
Deferred long term asset charges - - - - 0.00000M
Non current assets total 1.71M 1.22M 3.44M 2.56M 2.23M
Capital lease obligations 0.87M 0.45M 0.34M 0.41M 0.00000M
Long term debt total - - - - 0.00000M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.27100M -0.03400M -0.10000M -0.10000M -0.10000M
Change to liabilities 0.00000M 0.22M 0.46M 0.16M 0.28M
Total cashflows from investing activities - -0.03400M -0.12300M -0.03500M -0.05800M
Net borrowings 0.07M -0.86500M 0.71M 1.37M 1.29M
Total cash from financing activities 3.96M 4.23M 4.34M 4.47M 3.64M
Change to operating activities 0.02M 0.02M 0.00900M -0.02100M 0.00100M
Net income -4.47300M -7.08000M -8.43200M -10.69000M -10.22100M
Change in cash 0.89M 0.25M 0.06M 0.06M -0.33500M
Begin period cash flow 0.96M 0.72M 0.66M 0.66M 0.99M
End period cash flow 1.85M 0.96M 0.72M 0.66M 0.66M
Total cash from operating activities -2.76200M -3.93700M -4.15400M -4.42200M -3.89100M
Issuance of capital stock 3.84M 4.93M 3.63M 0.66M 1.84M
Depreciation 0.04M 0.02M 0.06M 0.07M 0.05M
Other cashflows from investing activities - - - - 0.00000M
Dividends paid - - - - 0.00000M
Change to inventory -0.03500M 0.04M -0.26100M -0.00900M 0.03M
Change to account receivables -0.55100M -0.02900M -0.14200M -0.12100M -0.16300M
Sale purchase of stock - - - - 0.00000M
Other cashflows from financing activities - 0.05M 0.85M 2.41M 1.51M
Change to netincome - 2.75M 2.53M 2.77M 3.35M
Capital expenditures 0.27M 0.02M 0.02M 0.04M 0.06M
Change receivables - - - - 0.00000M
Cash flows other operating - - - - 0.00000M
Exchange rate changes - - - - 0.00000M
Cash and cash equivalents changes - - - - 0.00000M
Change in working capital -0.25000M 0.25M 0.07M 0.03M 0.15M
Stock based compensation 2.07M 1.87M 2.46M 1.52M -
Other non cash items 0.31M 0.50M 2.47M 4.30M 4.53M
Free cash flow -3.03300M -3.97100M -4.17700M -4.45700M -3.94900M

Peer Comparison

Sector: Basic Materials Industry: Chemicals

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
BLGO
BioLargo Inc		 0.0025 1.19% 0.21 - - 3.14 6.91 3.07 -10.3339
SHECY
Shin-Etsu Chemical Co Ltd ADR		 -0.29 1.80% 15.84 18.83 12.18 0.03 2.62 0.03 0.06
SHECF
Shin-Etsu Chemical Co. Ltd		 -1.33 3.96% 32.23 18.24 12.11 0.03 2.68 0.03 0.06
BASFY
BASF SE ADR		 0.19 1.58% 12.25 - 11.93 0.66 1.10 0.94 21.29
BFFAF
BASF SE NA O.N.		 -0.71 1.40% 50.00 83.72 12.15 0.66 1.14 0.92 7.92

Reports Covered

Stock Research & News

View All

Profile

BioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.

BioLargo Inc

14921 Chestnut Street, Westminster, CA, United States, 92683

Key Executives

Name Title Year Born
Mr. Dennis P. Calvert Chairman, Pres & CEO 1963
Mr. Charles K. Dargan II, C.F.A. Chief Financial Officer 1955
Mr. Joseph L. Provenzano Exec. VP of Operations, Corp. Sec. & Director 1969
Mr. Kenneth Reay Code Chief Science Officer & Director 1947
Mr. Steven V. Harrison II Pres of Clyra Medical Technologies Inc 1959
Mr. Randall Moore Pres of BioLargo Engineering, Science & Technologies NA
Dr. Richard Smith Pres of BioLargo Water NA
Mr. Dennis P. Calvert Chairman, President & CEO 1963
Mr. Joseph L. Provenzano Executive VP of Operations, Corporate Secretary & Director 1969
Mr. Alex Evans Director of Corporate Communications NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.